SCHEMBL366286

SCHEMBL366286

CCOC(=O)c1c2ccccc2n2cc(N3CCOCC3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
GAA P10253 3/20 0.48
RXFP1 Q9HBX9 1/20 0.48
LMNA P02545 1/20 0.47
TSHR P16473 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 2/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366285 0.83 ALDH1A1 (0.54) MAPTGAARXFP1LMNATSHR
SCHEMBL365016 0.81 KDM4E (0.50) MAPTTSHRSMN1; SMN2NPC1RAB9A
SCHEMBL365361 0.80 PPARG (0.49) GAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL364761 0.78 KDM4E (0.52) MAPTGAALMNATSHRMAPK1
SCHEMBL364969 0.76 KDM4E (0.53) MAPTGAALMNATSHRMAPK1
SCHEMBL364770 0.76 ELANE (0.48) MAPTGAALMNAMAPK1MEN1
SCHEMBL364713 0.75 NPSR1 (0.48) MAPTLMNATSHRNPSR1MAPK1
SCHEMBL366638 0.74 KDM4E (0.47) MAPTGAALMNANPSR1MAPK1
SCHEMBL367142 0.74 KDM4E (0.47) MAPTGAALMNAMAPK1SMN1; SMN2
SCHEMBL364758 0.73 MEN1 (0.44) MAPTGAALMNATSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed